Comorbidity of migraine in children presenting with epilepsy to a tertiary care center

Neurology

Volumn 79, Issue 5, 2012, Pages 468-473

  Kelley, Sarah A ^a   Hartman, Adam L ^a   Kossoff, Eric H ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; ETIRACETAM; FELBAMATE; IBUPROFEN; LAMOTRIGINE; OXCARBAZEPINE; PARACETAMOL; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADOLESCENT; ARTICLE; BENIGN CHILDHOOD EPILEPSY; BENIGN EPILEPSY WITH CENTROTEMPORAL SPIKE; CHILD; COHORT ANALYSIS; COMORBIDITY; CROSS-SECTIONAL STUDY; FEMALE; HEADACHE; HIGH RISK POPULATION; HUMAN; INTRACTABLE EPILEPSY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIGRAINE; MYOCLONUS EPILEPSY; ONSET AGE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; TERTIARY HEALTH CARE;

EID: 84866101785     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182617113     Document Type: Article

References (27)

1. Lewis D, Ashwal S, Hershey A, et al. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology 2004;63:2215-2224.
2. Theodore WH, Spencer SS, Wiebe S, et al. Epilepsy in North America: a report prepared under the auspices of the global campaign against epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization. Epilepsia 2006;47: 1700-1722.
3. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 1991;32:429-445.
4. Ottman R, Lipton RB. Comorbidity of migraine and epilepsy. Neurology 1994;44:2105-2110.
5. Syvertsen M, Helde G, Stovner LJ, Brodtkorb E. Headaches add to the burden of epilepsy. J Headache Pain 2007;8:224-230.
6. Yankovsky AE, Andermann F, Bernasconi A. Characteristics of headache associated with intractable partial epilepsy. Epilepsia 2005;46:1241-1245.
7. Stevenson SB. Epilepsy and migraine headache: is there a connection? J Pediatr Health Care 2006;20:167-171.
8. Yamane LE, Montenegro MA, Guerreiro MM. Comorbidity headache and epilepsy in childhood. Neuropediatrics 2004;35:99-102.
9. Clarke T, Baskurt Z, Strug LJ, Pal DK. Evidence of shared genetic risk factors for migraine and rolandic epilepsy. Epilepsia 2009;50:2428-2433.
10. Wirrell EC, Hamiwka LD. Do children with benign rolandic epilepsy have a higher prevalence of migraine than those with other partial epilepsies or nonepilepsy controls? Epilepsia 2006;47:1674-1681.
11. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004; 24(suppl 1):9-160.
12. Berg AT, Vickrey BG, Testa FM, et al. How long does it take for epilepsy to become intractable? A prospective investigation. Ann Neurol 2006;60:73-79.
13. Lam GM, Edelson DP, Whelan CT. Lamotrigine: an unusual etiology for aseptic meningitis. Neurologist 2010;16:35-36.
14. Boot B. Recurrent lamotrigine-induced aseptic meningitis. Epilepsia 2009;50:968-969.
15. Hershey AD, Kabbouche MA, Powers SW. Treatment of pediatric and adolescent migraine. Pediatr Ann 2010;39: 416-423.
16. Papetti L, Spalice A, Nicita F, et al. Migraine treatment in developmental age: guidelines update. J Headache Pain 2010;11:267-276.
17. Toldo I, Perissinotto E, Menegazzo F, et al. Comorbidity between headache and epilepsy in a pediatric headache center. J Headache Pain 2010;11:235-240.
18. Ludvigsson P, Hesdorffer D, Olafsson E, Kjartansson O, Hauser WA. Migraine with aura is a risk factor for unprovoked seizures in children. Ann Neurol 2006;59:490-498.
19. Lewis DW, Ashwal S, Dahl G, et al. Practice parameter: evaluation of children and adolescents with recurrent headaches: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2002;59:490-498.
20. Kasteleijn-Nolst Trenité DG, Verrotti A, Di Fonzo A, et al. Headache, epilepsy and photosensitivity: how are they connected? J Headache Pain 2010;11:469-476.
21. Parisi P, Piccioli M, Villa MP, Buttinelli C, Kasteleijn-Nolst Trenité DG. Hypothesis on neurophysiopathological mechanism linking epilepsy and headache. Med Hypotheses 2008;70:1150-1154.
22. Santucci M, Giovanardi Rossi P, Ambrosetto G, Sacquegna T, D'Alessandro R. Migraine and benign epilepsy with rolandic spikes in childhood: a case-control study. Dev Med Child Neurol 1985;27:60-62.
23. Clarke T, Baskurt Z, Strug LJ, Pal DK. Evidence of shared genetic risk factors for migraine and rolandic epilepsy. Epilepsia 2009;50:2428-2433.
24. Schankin CJ, Remi J, Klaus I, et al. Headache in juvenile myoclonic epilepsy. J Headache Pain 2011;12:227-233.
25. Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB. Patterns of diagnosis and acute preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention Study. Headache 2007;47:355-363.
26. Winner P. Classification of Pediatric headache. Curr Pain Headache Rep 2008;12:357-360.
27. Liveing E. On Megrim, Sick Headache and Some Allied Disorders: A Contribution to the Pathology of Nerve Storms. London: J. and A. Churchill; 1873.